No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys (2)
Shulman John D
$110K
bought
Cohen Scot
$24K
bought
Sells (1)
Norris Elwood G
$364K
sold
No tracked top-trader positions in WRAP as of Oct 21, 16:01 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 11, 2026
Period ending
Jun 30, 2026
Earnings per share
EPS comparison unavailable
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | Unavailable | - | $2.1M No estimate | Unavailable |
| Mar 31, 2026 | Apr 23, 2026 | Unavailable | - | $1.1M No estimate | Unavailable |
| Dec 31, 2025 | Mar 26, 2026 | Unavailable | - | $1.4M No estimate | Unavailable |
| Sep 30, 2025 | Nov 12, 2025 | Unavailable | - | $1.5M No estimate | Unavailable |
| Jun 30, 2025 | Aug 14, 2025 | Unavailable | - | $1.0M No estimate | Unavailable |
| Mar 31, 2025 | May 15, 2025 | Unavailable | - | $765.0K No estimate | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | Unavailable | - | $865.0K No estimate | Unavailable |
| Sep 30, 2024 | Oct 15, 2024 | Unavailable | - | $593.0K No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.5M | $1.4M | $1.1M | $2.1M |
| Cost of what it sold | $608.0K | $670.0K | $420.0K | $507.0K |
| Gross profit | $883.0K | $734.0K | $691.0K | $1.5M |
| What it spent | ||||
| Research and development | $167.0K | $563.0K | $105.0K | $152.0K |
| Sales and admin | $3.5M | $4.4M | $5.4M | $3.6M |
| Other operating costs | — | -$314.0K | — | — |
| Total operating expenses | $3.6M | $4.7M | $5.5M | $3.8M |
| What was left | ||||
| Operating profit | -$2.8M | -$3.9M | -$4.8M | -$2.3M |
| Profit before tax | -$2.8M | -$3.9M | -$4.5M | -$2.3M |
| Net profit | -$2.8M | -$3.9M | -$4.5M | -$2.3M |
| EBITDA | -$2.6M | -$3.2M | -$4.5M | -$2.2M |
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace